Bide Pharmatech Co
As a high-tech enterprise, Bide Pharmatech researches, develops, manufactures and sells pharmaceutical intermediates and offers custom synthesis.
- Public company
- Shanghai, SH, CNChina
As a high-tech enterprise, Bide Pharmatech researches, develops, manufactures and sells pharmaceutical intermediates and offers custom synthesis.
Which advantages over its rivals hold up, and why are they hard to copy?
Bide Pharmatech Co holds an advantage in catalog scale: the firm supplies over 400,000 varieties of building blocks, more than 86,000 of them held in stock, so a buyer can source many compounds from one supplier. Its core technologies span custom synthesis of drug molecular building blocks, structural confirmation, and purity testing.
Its end customers comprise innovative pharmaceutical companies, research institutes, and CRO institutions.
What could change its growth trajectory, and what would confirm it?
Bide Pharmatech's growth trajectory has held, and the year-over-year sales line in its earnings reports is the indicator that would confirm or break that judgment. Full-year 2025 sales reached CNY 1,323.81 million, up from CNY 1,102.01 million in the prior year, and half-year 2026 sales reached CNY 682.79 million, up from CNY 627.53 million in the prior year.
Full-year 2025 net income reached CNY 152.2 million, up from CNY 117.43 million in the prior year.
What is the investment case, and what must be true for it to hold?
Bide Pharmatech Co can sustain growth from an already sizable sales base, and that case stands only while each reporting period tops the year-ago figures. Full-year 2025 sales totaled CNY 1,323.81 million, compared with CNY 1,102.01 million in the prior year. Full-year 2025 net income came to CNY 152.2 million, above the CNY 117.43 million recorded a year earlier.
Half-year 2026 sales reached CNY 682.79 million, up from CNY 627.53 million a year earlier. Bide Pharmatech Co is expanding into drug-discovery hubs across North America, South America, Western Europe, Eastern Europe, the Middle East and Southeast Asia.
What does the product do for its buyer, and how is it delivered?
Bide Pharmatech sorts its molecular building blocks by molecular structure to support successive stages of drug discovery. The blocks are grouped into benzene-ring, heterocyclic, and aliphatic classes, and they serve stages running from target discovery and hit screening through lead discovery, synthesis, and optimization to candidate discovery.
Production of these blocks runs from laboratory scale and pilot scale up to industrial scale.